Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer’s Disease
Authors:
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 40 (10) , 592-602
Abstract
No abstract availableKeywords
Funding Information
- NIH (AG034618, AG035015)
This publication has 88 references indexed in Scilit:
- Vps35‐dependent recycling of Trem2 regulates microglial functionTraffic, 2016
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease PhenotypesPLOS ONE, 2016
- The amyloid hypothesis of Alzheimer's disease at 25 yearsEMBO Molecular Medicine, 2016
- Pharmacological chaperones stabilize retromer to limit APP processingNature Chemical Biology, 2014
- Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cellsNature, 2012
- Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in YeastScience, 2011
- Apolipoprotein E RecyclingArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- A Dynamic Relationship between Intracellular and Extracellular Pools of AβThe American Journal of Pathology, 2006
- Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndromeNeurobiology of Aging, 2004
- A New Low Density Lipoprotein Receptor Related Protein, LRP5, Is Expressed in Hepatocytes and Adrenal Cortex, and Recognizes Apolipoprotein EThe Journal of Biochemistry, 1998